Home > Products > Biosimilars

BioSIM anti-Human PD-1/CD279 Antibody (Pembrolizumab Biosimilar), Research Grade

Catalog: SIM0030
Cost advantage to: SIM0010
Isotype: IgG4-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic Pembrolizumab biosimilar, ideal for research, shares the therapeutic antibody’s variable regions and binds human PD-1 (CD279). PD-1 (50-55 kDa, Pdcd1-encoded, CD28 family) is transiently expressed on immune cells, has an ITIM, binds PD-L1/2 to inhibit T cells, and supports peripheral tolerance. Tumor PD-L1 overexpression resists CD8 T-cell lysis; anti-PD-1 aids cancer treatment. This biosimilar blocks PD-1-ligand interaction.
 

Specifications

Product Name BioSIM anti-Human PD-1/CD279 Antibody (Pembrolizumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG4-kappa
Target PD-1/CD279
Other Names MK-3475, CAS: 1374853-91-4
CAS 1374853-91-4
Reactivity Human
Host Species Humanized
Background This non-therapeutic Pembrolizumab biosimilar, ideal for research, shares the therapeutic antibody’s variable regions and binds human PD-1 (CD279). PD-1 (50-55 kDa, Pdcd1-encoded, CD28 family) is transiently expressed on immune cells, has an ITIM, binds PD-L1/2 to inhibit T cells, and supports peripheral tolerance. Tumor PD-L1 overexpression resists CD8 T-cell lysis; anti-PD-1 aids cancer treatment. This biosimilar blocks PD-1-ligand interaction.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products